MAI Capital Management - SEELOS THERAPEUTICS INC ownership

SEELOS THERAPEUTICS INC's ticker is SEEL and the CUSIP is 81577F109. A total of 84 filers reported holding SEELOS THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.24 and the average weighting 0.0%.

Quarter-by-quarter ownership
MAI Capital Management ownership history of SEELOS THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$3,072
-99.7%
16,695
-98.0%
0.00%
-100.0%
Q2 2023$1,017,425
+58.7%
851,402
-8.2%
0.02%
+50.0%
Q1 2023$641,034
-7.6%
927,422
-9.3%
0.01%
-16.7%
Q4 2022$693,943
-45.3%
1,022,008
-17.0%
0.01%
-50.0%
Q3 2022$1,268,000
+267.5%
1,230,810
+142.6%
0.02%
+242.9%
Q2 2022$345,000507,4160.01%
Other shareholders
SEELOS THERAPEUTICS INC shareholders Q3 2023
NameSharesValueWeighting ↓
Uniplan Investment Counsel, Inc. 2,033,020$1,904,0000.13%
1492 Capital Management LLC 150,000$141,0000.11%
Spark Investment Management LLC 13,100$12,0000.02%
ARDSLEY ADVISORY PARTNERS LP 80,000$75,0000.01%
GSA CAPITAL PARTNERS LLP 27,437$26,0000.00%
WealthPLAN Partners, LLC 20,000$18,0000.00%
CIBC WORLD MARKET INC. 500,000$468,0000.00%
CAPITAL COUNSEL LLC/NY 10,000$9,0000.00%
J.W. COLE ADVISORS, INC. 10,000$9,0000.00%
Renaissance Technologies 591,086$554,0000.00%
View complete list of SEELOS THERAPEUTICS INC shareholders